Sienna Biopharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2015 | 0 | -11.29M | |
|---|---|---|---|
| 2016 | 0 | -21.82M | |
| 2017 | 0 | -50.54M | |
| 2018 | 0 | -73.31M | |
| 2019 | 0 | 0 | |
| 2020 | 0 | 0 | |
| 2021 | 0 | 0 | |
| 2022 | 0 | 0 |
SNNAQ Income Statement (2015 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 120K | 0 | 32K |
Gross profit | 0 | 0 | 0 | 0 | 0 | -120K | 0 | -32K |
Operating exp. | ||||||||
Research and development | 0 | 0 | 0 | 0 | 51.59M | 30.48M | 10.99M | 2.40M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 0 | 0 | 0 | 0 | 76.49M | 48.57M | 20.68M | 11.11M |
Operating income | 0 | 0 | 0 | 0 | -76.49M | -48.57M | -20.68M | -11.11M |
Other income (expenses), net | 0 | 0 | 0 | 0 | 3.02M | -2.26M | -473K | -184K |
Income before tax | 0 | 0 | 0 | 0 | -73.47M | -50.83M | -21.16M | -11.29M |
Income tax expense | 0 | 0 | 0 | 0 | -157K | -290K | 663K | 0 |
Net income | 0 | 0 | 0 | 0 | -73.31M | -50.54M | -21.82M | -11.29M |
Earnings per share | ||||||||
Basic EPS | 0 | 0 | 0 | 0 | -3.59 | -5.19 | -11.23 | -5.81 |
Diluted EPS | 0 | 0 | 0 | 0 | -3.59 | -5.19 | -11.23 | -5.81 |